 Moneycontrol.com | Developing world supports India's compulsory licence policy Moneycontrol.com CNBC-TV18. India's grant of a compulsory licence to Natco for Bayer's kidney-cancer drug Nexavar has sent shockwaves across the globe. As Bayer and the Indian government get ready to lock horns in court next week, developed and developing countries ... Experts divided over compulsory drug licence dispute |
